Matrix metalloproteinases and their inhibitors

Acta Orthopaedica

Volumn 66, Issue S266, 1995, Pages 55-60

  Murphy, Gillian ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; COLLAGEN; COLLAGENASE; ELASTASE; GELATINASE; GELATINASE B; MATRILYSIN; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; GLYCOPROTEIN;

AMINO ACID SEQUENCE; ARTHRITIS; ARTICULAR CARTILAGE; CARTILAGE; CONNECTIVE TISSUE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME BINDING; ENZYME INHIBITION; ENZYME INHIBITOR INTERACTION; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PROTEIN DEGRADATION; SHORT SURVEY; TRANSCRIPTION REGULATION; ANIMAL; BINDING SITE; BONE MATRIX; DRUG ANTAGONISM; ENZYME SPECIFICITY; ENZYMOLOGY; GENETICS; METABOLISM; REVIEW; SYNOVIAL FLUID;

AMINO ACID SEQUENCE; ANIMALS; ARTHRITIS; BINDING SITES; BONE MATRIX; COLLAGEN; EXTRACELLULAR MATRIX; GLYCOPROTEINS; HUMANS; METALLOENDOPEPTIDASES; SUBSTRATE SPECIFICITY; SYNOVIAL FLUID; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0029383456     PISSN: 17453674     EISSN: None     Source Type: Journal    
DOI: 10.3109/17453679509157648     Document Type: Article

References (53)

1. Binding of latent and high Mr active forms of stromelysin to collagen is mediated by the C-terminal domain
2. The binding of gelatinases A and B to type 1 collagen and other matrix components
3. Cloning of the cDNA encoding human tissue inhibitor of metalloproteinases-3 (TIMP-3) and mapping of the TIMP3 gene to chromosome 22
4. Gene encoding a novel murine tissue inhibitor of metalloproteinases (TIMP), TIMP-3, is expressed in developing mouse epithelia, cartilage, and muscle, and is located on mouse chromosome 10
5. Immunolocalization of metalloproteinases and their inhibitor in the rabbit growth plate
6. Inhibition of cartilage proteoglycan release by a specific inactivator of cathepsin B and an inhibitor of matrix metalloproteinases. Evidence for two converging pathways of chondrocyte-mediated proteoglycan degradation
7. The measurement of collagenase, tissue inhibitor of metalloproteinases (TIMP), and collagenase-TIMP complex in synovial fluids from patients with osteoarthritis and rheumatoid arthritis
8. Human progelatinase A can be activated by autolysis at a rate that is concentration-dependent and enhanced by heparin bound to the C-terminal domain
9. Production of collagenase and prostaglandins by isolated adherent rheumatoid synovial cells
10. Evidence for metalloproteinase and metal-loproteinase inhibitor imbalance in human osteoarthritic cartilage
11. The tissue metalloproteinase family and the inhibitor TIMP: a study using cDNAs and recombinant proteins. Ann
12. The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases
13. Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage
14. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins
15. The interglobular domain of cartilage aggrecan is cleaved by PUMP, gelatinases, and cathepsin B
16. Neutrophil collagenase (MMP-8) cleaves at the aggrecanase site E373-A374 in the interglobular domain of cartilage aggrecan
17. Cleavage of collagen type X by human synovial collagenase and neutrophil elastase
18. Degradation of cartilage collagens type II, IX, X and XI by enzymes derived from human articular chondrocytes
19. Secreted forms of human neutrophil collagenase
20. Characterization of a specific antiserum for mammalian collagenase from several species: immunolo-calization of collagenase in rabbit chondrocytes and uterus
21. Immunolocalisation studies on six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis
22. Metalloproteinase digestion of cartilage proteoglycan. Pattern of cleavage by stromelysin and susceptibility to collagenase
23. Mechanism of catabolism of aggrecan by articular cartilage
24. Metallo-proteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis
25. N-Terminal sequence of proteoglycan fragments isolated from medium of interleukin-1 treated articular-cartilage cultures
26. The matrix-degrading metalloproteinases
27. Expression of metalloproteinases and met-alloproteinase inhibitor inhuman arthritic synovium
28. The role of the C-terminal domain in collagenase and stromelysin specificity
29. The role of plasminogen activators in the regulation of connective tissue metalloproteinases
30. The C-terminal domain of 72 kDa gelat-inase A is not required for catalysis, but is essential for membrane activation and modulates interactions with tissue inhibitors of metalloproteinases
31. Extracellular matrix degradation
32. Substrate specificities and activation mechanisms of matrix metalloproteinases
33. Immunohistochemical demonstration of collagenase and tissue inhibitor of metalloproteinases (TIMP) in synovial lining cells of rheumatoid synovium
34. Localization of matrix metalloproteinase 3 (stromelysin) in osteoarthritic cartilage and synovium
35. A new inhibitor of metalloproteinases from chicken: ChIMP-3 A third member of the TIMP family
36. How do interleukin 1 and tumour necrosis factor induce degradation of proteoglycan in cartilage?
37. Catabolism of aggrecan in cartilage explants. Identification of a major cleavage site within the interglobular domain
38. A matrix metalloproteinase expressed on the surface of invasive tumour cells
39. Cloning of the genes for human stromelysin and stromelysin 2: different expression in rheumatoid synovial fibroblasts
40. The 21-kDa protein is a transformation-sensitive metalloproteinase inhibitor of chicken fibroblasts
41. The extracellular matrix ligands fibronectin and tenascin collaborate in regulating collagenase gene expression in fibroblasts
42. Binding of latent rheumatoid synovial collagenase to collagen fibrils
43. Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury
44. The purification of tissue inhibitor of metaHoproteinases-2 from its 72 kDa progelatinase complex Demonstration of the biochemical similarities of tissue inhibitor of metallopro-teinases-2 and tissue inhibitor of metalloproteinases-1
45. Tissue inhibitor of metalloproteinases-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes
46. Cell surface-mediated activation of progelatinase A: demonstration of the involvement of the C-terminal domain of progelatinase A in cell surface binding and activation of progelatinase A by primary fibroblasts
47. Human skin fibroblast collagenase: interaction with substrate and inhibitor
48. Signal transduction through the fibronectin receptor induces collagenase and stromelysin gene expression
49. Structure-function relationships in the tissue inhibitors of metalloproteinases
50. Differential in vivo expression of collagenase messenger RNA in synovium and cartilage
51. Collagenase at sites of cartilage erosion in the rheumatoid joint
52. Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage
53. Bafilomycin A inhibits IL-1-stimulated proteoglycan degradation by chondrocytes without affecting stromelysin synthesis